Skip to main content
Fig. 1 | Inflammation and Regeneration

Fig. 1

From: Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases

Fig. 1

Putative mechanisms of mesenchymal stem cell (MSC) and exosome therapy in severe COVID-19 cases. MSCs and their exosomes have a potent ability to ameliorate the cytokine storm observed in severe cases of COVID-19, and prevent progression toward acute respiratory distress syndrome (ARDS) and multiple organ failure (MOF). SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; IL, interleukin

Back to article page

Inflammation and Regeneration

ISSN: 1880-8190

Contact us